Dr. Reddy’s Laboratories Buys U.K. Dow Chemical Drug Units
This article was originally published in The Pink Sheet Daily
Move bolsters India firm’s contract research capabilities.
You may also be interested in...
Indian generics marketer experienced price erosion in the U.S. in the third quarter.
With the $576 mil. acquisition of Betapharm, Dr. Reddy’s will expand its presence in Europe.
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.